Safety study of IN-114199 in healthy volunteers
Part of Digestive system clinical trials.
This trial tests whether a new medicine, IN-114199, is safe in healthy adults. It also looks at how the body processes the drug and how food affects it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 63 years old.
- You generally have a bowel movement every day or almost every day.
- Your weight is between 88 and 220 pounds (BMI between 18.5 and 29.9).
- You do not have significant health problems or a history of stomach or bleeding disorders.
- You can avoid alcohol for at least a few days and limit caffeine before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called ID110521156 in healthy adults. The goal is to see if the drug is safe and how the body processes it. It may be for people who are overweight or obese.
This trial tests how the body processes a new tablet called IN-M00002, and how food affects its absorption. It is for healthy volunteers to help find the right dose and understand side effects.
This trial tests how two experimental drugs, IN-M00007 and IN-R00007, move through the body and how safe they are. It is for healthy adults to gather basic information before testing in patients.
This trial tests a new drug called CMTS4520 for people with long-term constipation. It aims to see if the drug can help you have more bowel movements without needing laxatives or other help. The study lasts for several months and includes regular check-ups.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests how a new experimental medicine (INCB123667) works and is tolerated in adults with moderate to severe liver problems. Researchers want to understand how the body processes this drug and whether it's safe in people with liver dysfunction.
Hear when a new Chronic Idiopathic Constipation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.